-
Some drugs can increase health risks during heat waves
As nearly 10 million people in the eastern U.S. feel a major heat wave this week, patients taking some medications have a higher risk of heat-related illnesses, The New York Times reported June 15. -
Sanders drops Novo Nordisk subpoena threat
Vermont Sen. Bernie Sanders has canceled a Senate committee vote that would have determined whether to subpoena Novo Nordisk executives about the cost of the drugmaker's blockbuster drugs, Ozempic and Wegovy. The move comes as Novo Nordisk's CEO agreed to participate in a Senate committee hearing set for September. -
Mark Cuban: Pharma has been 'easiest industry' to disrupt
It's unclear how much Mark Cuban can or will disrupt the pharmaceutical industry, but he told The Athletic he's in the business for the long haul. -
Pfizer's DMD gene therapy falls short in phase 3 trial
Pfizer's gene therapy candidate for Duchenne muscular dystrophy failed to meet its primary endpoint in a phase 3 trial, the company said June 12. -
At Houston Methodist, Alexa answers patients' medication questions
When Houston Methodist installed Amazon Echo Dots in its pharmacies and patient rooms, the system halved the time it takes for orders to be signed and medications to be administered by nurses, according to Pharmacy Practice News. -
CVS-branded drugs recalled 2x more than Walgreens, Walmart generics
Contaminated manufacturing may be what has led generic drugs at CVS to be recalled almost twice as often as generic drugs at Walgreens or Walmart, according to a June 10 report from Bloomberg. -
Outdated software causing near misses in pharmacies: Report
A workplace and well-being report has unveiled a new problem in pharmacies: outdated software and broken computer systems. -
32 state AGs press Supreme Court for more regulatory power on PBMs
A bipartisan group of 32 attorneys general is urging the Supreme Court to grant them more regulatory power over pharmacy benefit managers. -
AdventHealth partners with Pharmacy of Grace on low-cost meds, services
AdventHealth Shawnee Mission in Merriam, Kan., announced a $35,000 partnership with Pharmacy of Grace, a nonprofit in the Kansas City metropolitan area that provides pharmacy services to uninsured or underinsured patients. -
Mark Cuban company teams with 2,000 grocery stores
Team Cuban Card, an offering from Mark Cuban Cost Plus Drug Co., is now accepted at Food Lion, Giant Food, Hannaford and Stop & Shop. -
Another potential indication for Mounjaro, Zepbound
Tirzepatide, the main ingredient for Eli Lilly's Mounjaro and Zepbound, omitted the presence of metabolic dysfunction-associated steatohepatitis in a phase 2 study, the drugmaker said June 8. The trial results could precede another indication for the popular drugs. -
FDA panel votes in favor of Alzheimer's drug candidate
On June 10, a panel of FDA advisors voted 11-0 in favor of donanemab, an experimental Alzheimer's disease treatment from Eli Lilly. -
Hospital pharmacist wages grow 4%
Between 2022 and 2023, the average hospital pharmacist saw a 4% salary increase, according to a Drug Channels report. -
Moderna's combo flu, COVID-19 shot succeeds in phase 3 trial
On June 10, Moderna said its experimental combination vaccine for COVID-19 and influenza surpassed the efficacy of existing shots in a phase 3 trial. -
Kindred pharmacy director moves to Baptist
Louisville, Ky.-based Baptist Health named Rachel Connors, PharmD, as the pharmacy director of its hospital in New Albany, Ind. -
4 ways to use AI in health system pharmacies
Artificial intelligence has already started to transform hospital and health system functions, communications, imaging and other operations, but what role could it have in pharmacies? -
Inside Cleveland Clinic pharmacy chief's first 100 days
Cleveland Clinic's new chief pharmacy officer has a simple goal: No surprises. -
Minnesota is 7th state to approve 340B contract pharmacy protections
Minnesota is the seventh state to approve a new 340B contract pharmacy law that forbids drug manufacturers and distributors from limiting access to medications for hospitals and health systems serving uninsured and underinsured populations. -
Bristol Myers Squibb to lay off 860+ workers in New Jersey
Bristol Myers Squibb, one of 12 pharmaceutical and health service companies in the Fortune 500 list, plans to lay off 863 employees in Lawrenceville, N.J., according to recently filed WARN notices. -
New drug pricing dispute resolution rule to take effect: 7 other 340B hospital updates
Beginning June 18, a newly finalized rule from the Health Resources and Services Administration will take effect and change how the resolution of disputes within the 340B program is handled.
Page 4 of 50